[
  {
    "ts": null,
    "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of October 26",
    "summary": "Get the latest weekly summary on Dividend Champions, Contenders & Challengers. Track dividend changes, upcoming ex-dividend and pay dates.",
    "url": "https://finnhub.io/api/news?id=7fc308958146b9ec4bb25f8abfe9a4f65825f910f23ecfd76eea75fbef836524",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761328391,
      "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of October 26",
      "id": 137203722,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
      "related": "DHR",
      "source": "SeekingAlpha",
      "summary": "Get the latest weekly summary on Dividend Champions, Contenders & Challengers. Track dividend changes, upcoming ex-dividend and pay dates.",
      "url": "https://finnhub.io/api/news?id=7fc308958146b9ec4bb25f8abfe9a4f65825f910f23ecfd76eea75fbef836524"
    }
  },
  {
    "ts": null,
    "headline": "DHR Q3 2025 Deep Dive: Bioprocessing, Diagnostics, and Productivity Initiatives Amid Policy Shifts",
    "summary": "Diversified science and technology company Danaher (NYSE:DHR) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 4.4% year on year to $6.05 billion. On the other hand, next quarter’s revenue guidance of $6.70 billion was less impressive, coming in 4.7% below analysts’ estimates. Its non-GAAP profit of $1.89 per share was 9.8% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=b64a22610a47d13cbc7d27fd4152a670076395d91338c15d7228d7488f3c9d31",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761312653,
      "headline": "DHR Q3 2025 Deep Dive: Bioprocessing, Diagnostics, and Productivity Initiatives Amid Policy Shifts",
      "id": 137216532,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "Diversified science and technology company Danaher (NYSE:DHR) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 4.4% year on year to $6.05 billion. On the other hand, next quarter’s revenue guidance of $6.70 billion was less impressive, coming in 4.7% below analysts’ estimates. Its non-GAAP profit of $1.89 per share was 9.8% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=b64a22610a47d13cbc7d27fd4152a670076395d91338c15d7228d7488f3c9d31"
    }
  }
]